WP3 Pharmacovigilance

WP objectives:

  • To obtain access to international databases of spontaneous adverse reaction/adverse event reports on which to perform the study
  • To define and list cardiovascular, cerebrovascular and pancreatic events in spontaneous reports for blood glucose lowering agents.
  • To assess potential associations between T2DM drugs and cardiovascular, cerebrovascular and pancreatic events using disproportionality analyses.
  • To identify new potential safety signals for the study drugs.